Bausch Health Companies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,826	3,530	4,276	3,876	3,074	12,556
Market Cap Growth	-10.31%	-17.46%	10.32%	26.08%	-75.52%	33.74%
Enterprise Value	21,307	31,608	25,648	34,785	32,544	41,279
Last Close Price	4.89	9.53	11.62	10.61	8.49	34.93
PE Ratio	-	16.52	-	-	-	-
Forward PE	1.10	1.67	1.90	2.11	1.70	5.92
PEG Ratio	-	-	-	-	1.43	1.44
PS Ratio	0.17	0.25	0.31	0.33	0.28	1.18
PB Ratio	-	-4.64	-3.34	-2.86	-3.27	-93.72
P/FCF Ratio	1.76	3.52	3.39	4.74	-	8.59
P/OCF Ratio	1.28	2.52	2.68	3.76	-	6.97
EV/Sales Ratio	2.02	2.24	1.86	3.00	2.95	3.87
EV/EBITDA Ratio	5.90	8.55	7.36	13.70	12.98	16.31
EV/EBIT Ratio	8.82	12.70	11.56	27.26	52.83	72.58
EV/FCF Ratio	20.73	31.51	20.36	42.58	-	28.23
Debt / Equity Ratio	-18.39	54.68	-58.83	-267.54	78.21	-666.29
Debt / EBITDA Ratio	6.44	7.74	6.20	11.68	11.24	11.32
Debt / FCF Ratio	27.52	28.53	17.16	36.31	-	19.58
Net Debt / Equity Ratio	-9.46	-35.24	-15.96	-21.91	-30.01	-213.72
Net Debt / EBITDA Ratio	6.03	7.25	5.86	11.68	11.24	11.32
Net Debt / FCF Ratio	25.78	26.72	16.20	36.31	-21.95	19.58
Asset Turnover	0.47	0.46	0.42	0.33	0.30	0.28
Inventory Turnover	2.14	2.20	2.10	1.94	2.27	2.29
Quick Ratio	0.77	0.88	0.49	0.46	0.45	0.34
Current Ratio	1.32	1.47	0.86	1.30	1.08	1.08
Return on Equity (ROE)	344.16%	157.25%	47.00%	-686.52%	-187.61%	-328.20%
Return on Assets (ROA)	13.51%	13.53%	16.40%	1.57%	0.59%	1.62%
Return on Invested Capital (ROIC)	16.91%	16.21%	18.88%	1.83%	0.70%	1.94%
Return on Capital Employed (ROCE)	11.20%	10.08%	8.40%	4.30%	1.98%	1.79%
Earnings Yield	-	6.05%	-	-	-	-
FCF Yield	56.75%	28.42%	29.47%	21.08%	-	11.65%
Buyback Yield / Dilution	-0.81%	-1.90%	-0.85%	-0.80%	-0.86%	-1.10%
Total Shareholder Return	-0.81%	-1.90%	-0.85%	-0.80%	-0.86%	-1.10%

SEC Filings: 10-K · 10-Q